APCoronavirusIndiana NewsLocal News

Lilly antibody drug falls short in COVID-19 study

(Photo Supplied/ Eli Lilly)

INDIANAPOLIS (AP): U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help.

Independent monitors had paused enrollment in the study two weeks ago because of a possible safety issue. But on Monday, the National Institute of Allergy and Infectious Diseases, which sponsors the study, said a closer look found no safety problem but a low chance that the drug would prove helpful for hospitalized patients.

President Donald Trump received a similar drug when he was sickened earlier this month.

Related posts

Indianapolis School Officials Warn of Tuberculosis Exposure

WOWO News

Police Search for Alleged Armed Robber

Kylie Havens

Gary Man Dies from Burns in Fire that Killed Wife

Kayla Blakeslee

Leave a Comment